UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

The use of bifunctional NOP/mu and NOP receptor selective compounds for the treatment of pain, drug abuse, and psychiatric disorders

Current pharmaceutical design, 2013-12, Vol.19 (42), p.7451

Toll, Lawrence

2013

Link zum Volltext

Verfügbarkeit prüfen

Challenges for opioid receptor nomenclature: IUPHAR Review 9

British journal of pharmacology, 2015-01, Vol.172 (2), p.317-323

2015

Link zum Volltext

Verfügbarkeit prüfen

Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?

Drug discovery today, 2017-11, Vol.22 (11), p.1719-1729

2017

Link zum Volltext

Verfügbarkeit prüfen

NOP-Related Mechanisms in Pain and Analgesia

Handbook of experimental pharmacology, 2019-01, Vol.254, p.165-186

2019

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the distribution of spinal NOP receptors in a chronic pain model using NOP‐eGFP knock‐in mice

British journal of pharmacology, 2018-07, Vol.175 (13), p.2662-2675

2018

Link zum Volltext

Verfügbarkeit prüfen

Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors

European journal of pharmacology, 2013-01, Vol.698 (1-3), p.228-234

2013

Link zum Volltext

Verfügbarkeit prüfen

Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists

Science signaling, 2019-03, Vol.12 (574)

2019

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Current Topics in Opioid Research

Frontiers in psychiatry, 2019-08, Vol.10, p.586-586

2019

Link zum Volltext

Verfügbarkeit prüfen

The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward

The Journal of pharmacology and experimental therapeutics, 2011-03, Vol.336 (3), p.952

2011

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine 308 Is Necessary for Ligand-directed Gs Protein-biased Signaling of β2-Adrenoceptor

The Journal of biological chemistry, 2014-07, Vol.289 (28), p.19351-19363

2014

Link zum Volltext

Verfügbarkeit prüfen

Designing bifunctional NOP receptor–mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I

Bioorganic & medicinal chemistry letters, 2013-06, Vol.23 (11), p.3308-3313

2013

Link zum Volltext

Verfügbarkeit prüfen

Activation of β2-adrenergic receptor by (R,R′)-4′-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells

Cellular signalling, 2015-05, Vol.27 (5), p.997-1007

2015

Link zum Volltext

Verfügbarkeit prüfen

Structural Determinants of Opioid and NOP Receptor Activity in Derivatives of Buprenorphine

Journal of medicinal chemistry, 2011-10, Vol.54 (19), p.6531-6537

2011

Link zum Volltext

Verfügbarkeit prüfen

Evolutionary sequence modeling for discovery of peptide hormones

PLoS computational biology, 2009-01, Vol.5 (1), p.e1000258-e1000258

2009

Link zum Volltext

Verfügbarkeit prüfen

Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia

The Journal of clinical investigation, 2008-07, Vol.118 (7), p.2471-2481

2008

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profile

Frontiers in psychiatry, 2018-09, Vol.9, p.430-430

2018

Link zum Volltext

Verfügbarkeit prüfen

PPL-103: A mixed opioid partial agonist with desirable anti-cocaine properties

Progress in neuro-psychopharmacology & biological psychiatry, 2022-12, Vol.119, p.110599-110599, Article 110599

2022

Link zum Volltext

Verfügbarkeit prüfen

The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies

CNS drugs, 2021-06, Vol.35 (6), p.591-607

2021

Link zum Volltext

Verfügbarkeit prüfen

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

Nature (London), 1995-10, Vol.377 (6549), p.532-535

1995

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Isohasubanan Alkaloids via Enantioselective Ketone Allylation and Discovery of an Unexpected Rearrangement

Journal of organic chemistry, 2009-02, Vol.74 (3), p.1187-1199

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective β2-adrenergic receptor agonists

Bioorganic & medicinal chemistry, , Vol.18 (2), p.728-736

Link zum Volltext

Verfügbarkeit prüfen

Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems

Pharmacological reviews, 2016-04, Vol.68 (2), p.419-457

2016

Link zum Volltext

Verfügbarkeit prüfen

Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOP

The AAPS journal, 2005-10, Vol.7 (2), p.E345-E352

2005

Link zum Volltext

Verfügbarkeit prüfen

Regulation of the prepronociceptin gene and its effect on neuronal differentiation

Gene, 2006-12, Vol.384, p.27-36

2006

Link zum Volltext

Verfügbarkeit prüfen

PPL-138 (BU10038): A bifunctional NOP/mu partial agonist that reduces cocaine self-administration in rats

Neuropharmacology, 2022-06, Vol.211, p.109045-109045, Article 109045

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Englisch
(176)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The use of bifunctional NOP/mu and NOP receptor selective compounds for the treatment of pain, drug abuse, and psychiatric disorders

Challenges for opioid receptor nomenclature: IUPHAR Review 9

Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?

NOP-Related Mechanisms in Pain and Analgesia

Analysis of the distribution of spinal NOP receptors in a chronic pain model using NOP‐eGFP knock‐in mice

Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors

Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists

Editorial: Current Topics in Opioid Research

The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward

Tyrosine 308 Is Necessary for Ligand-directed Gs Protein-biased Signaling of β2-Adrenoceptor

Designing bifunctional NOP receptor–mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I

Activation of β2-adrenergic receptor by (R,R′)-4′-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells

Structural Determinants of Opioid and NOP Receptor Activity in Derivatives of Buprenorphine

Evolutionary sequence modeling for discovery of peptide hormones

Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia

Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profile

PPL-103: A mixed opioid partial agonist with desirable anti-cocaine properties

The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

Synthesis of Isohasubanan Alkaloids via Enantioselective Ketone Allylation and Discovery of an Unexpected Rearrangement

Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective β2-adrenergic receptor agonists

Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems

Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOP

Regulation of the prepronociceptin gene and its effect on neuronal differentiation

PPL-138 (BU10038): A bifunctional NOP/mu partial agonist that reduces cocaine self-administration in rats

Suchergebnisse filtern